Patents by Inventor Kristianna Baldwin Weymann

Kristianna Baldwin Weymann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants
    Publication number: 20020152499
    Abstract: The invention concerns the location and characterization of a gene (designated NIM1) that is a key component of the SAR pathway and that in connection with chemical and biological inducers enables induction of SAR gene expression and broad spectrum disease resistance in plants. The invention further concerns transformation vectors and processes for overexpressing the NIM1 gene in plants. The transgenic plants thus created have broad spectrum disease resistance.
    Type: Application
    Filed: February 19, 2002
    Publication date: October 17, 2002
    Inventors: John Andrew Ryals, Terrence Patrick Delaney, Leslie Bethards Friedrich, Kristianna Baldwin Weymann, Kay Ann Lawton, Daniel Murray Ellis, Scott Joseph Uknes, Taco Peter Jesse, Pieter Vos
  • Method for breeding disease resistance into plants
    Patent number: 6107544
    Abstract: Methods are provided for selecting parental plants exhibiting disease resistance and for using these plants in breeding programs. In one method of the invention, constitutive immunity (cim) mutants are screened for either resistance to a pathogen of interest or for the expression of systemic acquired resistance (SAR) genes. Such mutants having the desired traits or expressing the desired genes are then used in breeding programs. Parent plants can also be selected based on the constitutive expression of SAR genes. These mutants are phenotypically normal yet exhibit a significant level of disease resistance. Also disclosed are lesion-simulating-disease (lsd) mutants having a lesion mimic phenotype that also express SAR genes and exhibit disease resistance. Further disclosed are non-inducible immunity (nim) mutants that do not express SAR genes, even when induced by a pathogen. Methods of use for these mutants are also disclosed.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: August 22, 2000
    Assignee: Novartis Finance Corporation
    Inventors: John Andrew Ryals, Scott Joseph Uknes, Eric Russell Ward, Terrence Patrick Delaney, Kay Ann Lawton, Kristianna Baldwin Weymann, Henry-York Steiner, Klaus Maleck
  • Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants
    Patent number: 6091004
    Abstract: The invention concerns the location and characterization of a gene (designated NIM1) that is a key component of the SAR pathway and that in connection with chemical and biological inducers enables induction of SAR gene expression and broad spectrum disease resistance in plants. The invention further concerns transformation vectors and processes for overexpressing the NIM1 gene in plants. The transgenic plants thus created have broad spectrum disease resistance.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: July 18, 2000
    Assignee: Novartis Finance Corporation
    Inventors: John Andrew Ryals, Terrence Patrick Delaney, Leslie Bethards Friedrich, Kristianna Baldwin Weymann, Kay Ann Lawton, Daniel Murray Ellis, Scott Joseph Uknes, Taco Peter Jesse, Pieter Vos